Lecanemab: European drug agency rejects Alzheimer's drug amid debate over efficacy and safety
- PMID: 39074878
- DOI: 10.1136/bmj.q1692
Lecanemab: European drug agency rejects Alzheimer's drug amid debate over efficacy and safety
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical